SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 2.26 |
| Enterprise Value ($M) | -0.63 |
| Book Value ($M) | 3.72 |
| Book Value / Share | 0.79 |
| Price / Book | 0.61 |
| NCAV ($M) | 3.62 |
| NCAV / Share | 0.76 |
| Price / NCAV | 0.62 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -3.02 |
| Return on Assets (ROA) | -1.99 |
| Return on Equity (ROE) | -2.31 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.97 |
| Current Ratio | 3.97 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4.84 |
| Assets | 4.94 |
| Liabilities | 1.22 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Warrants | n/a |
| Earnings Per Share Common Shares Issued And Outstanding Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Common Shares Issued And Outstanding Basic | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q | ||
| United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q | ||
| United States Securities and Exchange Commission Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 11,957 | 34,992 | 34.17 | |
| 13,464 | 71,527 | 18.82 | |
| 5,442 | 28,453 | 19.13 | |
| 968 | 40,877 | 2.37 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| OTLK – Outlook Therapeutics, Inc. | PALI – Palisade Bio, Inc. |
| PASG – Passage Bio, Inc. | PDSB – PDS Biotechnology Corporation |
| PHIO – Phio Pharmaceuticals Corp. |
Financial data and stock pages provided by
Fintel.io